MINNEAPOLIS — Bio-Techne has released MimEX™ GI, a new product line for generating 3-dimensional (3-D) gastrointestinal tissue on a 2-D surface. 3-D cell culture and organoid models of the gastrointestinal epithelium are quickly being adopted for toxicology, drug discovery, and disease modeling. These more complex models provide a tremendous benefit over cell line- and primary cell-based methods […]
Ortenberg, Germany – Cell-based assays have become an important application in the life science sector, from basic to top-level research. They are widely used in biotech companies and academic research institutions to monitor cell health in real-time. As experiments with living cells require constant physiological conditions, a precise gas control is essential. Our latest Atmospheric Control […]
SYDNEY, AUSTRALIA / Medical clinic and research facility Olympus Stem Cells Pty Ltd, based in Sydney Olympic Park, NSW, Australia, are pleased to announce the validation of 100% medical stem cell viability confirmed with Muse cell analyzer technology as described by Millipore Merck. More details can be obtained from https://www.olympusstemcells.com.au or https://www.merckmillipore.com. The Director of Olympus Stem Cells, […]
VANCOUVER, BRITISH COLUMBIA – STEMCELL Technologies has signed an exclusive license with Indiana University Innovation and Commercialization Office for patented rights to groundbreaking inner ear organoid technologies. The inner ear contains organs responsible for detecting sounds and maintaining balance, both of which are mediated by a sensory cell called the hair cell due to its specialized protrusions resembling tiny […]
Houston, TX and Emeryville, CA – The University of Texas MD Anderson Cancer Center and Berkeley Lights, Inc. today announced the launch of Optera Therapeutics Corp, a biopharmaceutical company developing cell therapies with scalable manufacturing solutions for cancer. Cell-based immunotherapies where patients are treated with their own immune cells, such as chimeric antigen receptor (CAR-T) and […]
AMSBIO reports on ground breaking research** by the Institute for Research in Biomedicine (IRB), Barcelona that cites use of its proprietary 3D organoid technology to develop a mouse model that mimics advanced human colon cancer. This model has allowed them to study the immune system response for the first time. In a short space of […]
Yokogawa Electric Corporation (TOKYO: 6841) announces the release of the CellLibrarian™ high-content data management system. This system facilitates the retrieval and categorization of huge volumes of microscopic images taken for drug discovery and biological and medical research by ensuring that this data is managed in a uniform manner. The CellLibrarian image data management system is intended […]
Cellular imaging acquisition and analysis system at an affordable price point San Jose, Calif. – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of its ImageXpress® Pico Automated Cell Imaging System. Building on over 20 years of experience in the high content imaging space, this compact, affordable imaging system brings […]
WALTHAM, Mass.–Minerva Biotechnologies, a leading cancer immunotherapy and regenerative medicine company, announces European distribution agreement with CellSystems GmbH a major European life science supplier, for AlphaSTEM™ Naïve Stem Cell Culture System. Minerva Biotechnologies is the first company to generate human naïve state induced pluripotent stem cells (iPS cells) using a single, naturally occurring human stem […]
RHS Limited (ASX: RHS) is pleased to announce that it has entered into a binding Scheme Implementation Agreement (“SIA”) with PerkinElmer, Inc. (“PerkinElmer”) PKI 0.74% for the acquisition by PerkinElmer of all of the issued share capital of RHS by way of a Scheme of Arrangement (“Scheme”) for $0.28 per share. The details of the SIA between PerkinElmer and RHS are […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
